This unit of study will cover the therapeutics of oncology and immunology including the pharmaceutical sciences that underpin such drug therapies. This unit will also include the epidemiology, pathophysiology and clinical features of oncology and immunology disorders. Topics covered include: allergic drug reactions, chemotherapy, antimicrobials, antifungals, cancer clinical trials, radiopharmaceuticals, complementary medicines in oncology, and the therapeutic application of antibodies. Through the use of case-based learning, students will participate in the interpretation, application and dissemination of pharmaceutical and pharmacotherapeutic concepts and knowledge. On completion of this unit of study students will be able to apply an understanding of the pharmaceutical sciences to optimising the drug and non-drug therapy of patients with oncology and immunology disorders. Interprofessional communication and the application of specialist knowledge to implementing pharmacist cognitive services such as clinical interventions and/or medication management review will also be explored. Students will become familiar with drug information software and a number of computerised drug information databases. Role-plays will be used to develop students' communication skills for interaction between pharmacists and their clients (patients, doctors, other health professionals).
2x3hr lectures/week, 1x2hr tutorials/week
1.5hr exam (70%), OSCE (20%), tutorial participation and presentations (10%)
Therapeutic Guidelines, Australian Medicines Handbook (latest version), MIMS, Clinical Pharmacy and Therapeutics, recommended resources and reading material from lectures and tutorials.
(BIOL1XX8 or BIOL1XX3) and (CHEM1611 or CHEM11X2 or CHEM19X2 or CHEM1904) and (CHEM1612 or CHEM11X1 or CHEM19X1 or CHEM1903) and (BIOL1XX7 or MBLG1XX1) and PHAR1811 and PHAR1812 and PHAR1821 and PHAR1822 and PCOL2605 and PHAR2811 and PHAR2812 and PHAR2813 and PHAR2821 and PHAR2822 and PHAR2823 and PHSI2601Co-requisites
PHAR3820 and PHAR3826 and PHAR3825 and PHAR3100